In four cases, tumours were wild type in primary sites, but were RAS mutant type in lung metastatic sites; in another 1 case, gene mutation changed from KRAS G12D and PIK3CA E545A in primary site to wild type in lung metastatic site. This evidence concerns the gene PIK3CA and neoplasm.